Stoke Therapeutics, Inc. STOK Increase Decrease In Accounts Payable Accrued Liabilities And Opertaing Leases
Increase Decrease In Accounts Payable Accrued Liabilities And Opertaing Leases at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept stok:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOpertaingLeases.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s increase decrease in accounts payable accrued liabilities and opertaing leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s increase decrease in accounts payable accrued liabilities and opertaing leases?
- Stoke Therapeutics, Inc. (STOK) reported increase decrease in accounts payable accrued liabilities and opertaing leases of -$15.72M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s increase decrease in accounts payable accrued liabilities and opertaing leases changed year-over-year?
- Stoke Therapeutics, Inc.'s increase decrease in accounts payable accrued liabilities and opertaing leases decreased by 431.6% year-over-year, from $4.74M to -$15.72M.
- What does increase decrease in accounts payable accrued liabilities and opertaing leases mean?
- This metric captures the net change in short-term liabilities, including trade payables, accrued expenses, and lease obligations, during the reporting period. It reflects the company's management of working capital and its ability to time payments to vendors and service providers. A positive change indicates an increase in cash retained by delaying outflows, while a negative change indicates cash used to settle obligations.